Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
Nature Communications
|
November 10, 2016
Vasculogenic mimicry in small cell lung cancer
Stuart C Williamson, Robert L Metcalf, Francesca Trapani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2012
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer
Charles M Rudin, Christine L Hann, Edward B Garon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2025
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
Jessica Menis, Laurent Greiller, Pierre Demontrond, et al.
Cell Reports
|
April 30, 2025
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer
Alessia Catozzi, Maria Peiris Pagès, Sam Humphrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial
Robert D Morgan, Andrew R Clamp, Daniel J White, et al.
Molecular Oncology
|
December 6, 2021
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection
Andi K Cani, Emily M Dolce, Elizabeth P Darga, et al.
Nature Medicine
|
October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Francesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Nature Medicine
|
June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Francesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
The Journal of Clinical Investigation
|
June 14, 2016
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf, Nadine S Jahchan, Peter J Schnorr, et al.
Molecular Oncology
|
August 5, 2020
Towards a cancer mission in Horizon Europe: recommendations
Anton Berns, Ulrik Ringborg, Julio E Celis, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
Nature Communications
|
November 10, 2016
Vasculogenic mimicry in small cell lung cancer
Stuart C Williamson, Robert L Metcalf, Francesca Trapani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 13, 2012
Phase II study of single-agent navitoclax (ABT-263) and biomarker correlates in patients with relapsed small cell lung cancer
Charles M Rudin, Christine L Hann, Edward B Garon, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 5, 2025
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer
Jessica Menis, Laurent Greiller, Pierre Demontrond, et al.
Cell Reports
|
April 30, 2025
Functional characterization of the ATOH1 molecular subtype indicates a pro-metastatic role in small cell lung cancer
Alessia Catozzi, Maria Peiris Pagès, Sam Humphrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 17, 2023
Multi-Maintenance Olaparib Therapy in Relapsed, Germline BRCA1/2-Mutant High-Grade Serous Ovarian Cancer (MOLTO): A Phase II Trial
Robert D Morgan, Andrew R Clamp, Daniel J White, et al.
Molecular Oncology
|
December 6, 2021
Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection
Andi K Cani, Emily M Dolce, Elizabeth P Darga, et al.
Nature Medicine
|
October 9, 2019
Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Francesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
Nature Medicine
|
June 5, 2020
Publisher Correction: Pulmonary venous circulating tumor cell dissemination before tumor resection and disease relapse
Francesca Chemi, Dominic G Rothwell, Nicholas McGranahan, et al.
The Journal of Clinical Investigation
|
June 14, 2016
CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer
Kipp Weiskopf, Nadine S Jahchan, Peter J Schnorr, et al.
Molecular Oncology
|
August 5, 2020
Towards a cancer mission in Horizon Europe: recommendations
Anton Berns, Ulrik Ringborg, Julio E Celis, et al.
Page
of 21